This post was published earlier on ZYX Buy Change Alert Based on legal developments today, recommendation on HGSI is now cancelled. Most investors who have already entered a tranche may consider exiting right here at $13.50 for a scratch. Based on a court’s ruling on poison pill, only very aggressive
This post was published earlier on ZYX Buy Change Alert Last year Human Genome Sciences Inc. (HGSI) successfully introduced the first new treatment for Lupus in a very long time. GlaxoSmithKline (GSK), the big drug giant, is Human Genome’s partner. Human Genome has disclosed that it received an unsolicited $13.00 per share cash offer
$HGSI stock is dipping in the premarket on the news that FDA says its anthrax drug may not work. Our analysis shows that the anthrax drug is not material to the future of this company. The stock price has risen due to the success of the Lupus drug. Any large